View Post

Third vaccine dose: trial

In News by John Geddes

A new clinical trial will investigate whether a third dose of vaccine for people with weakened immune systems gives a stronger immune response than two doses. The £2.2 million study …

View Post

OCTAVE study – initial findings

In News by John Geddes

OCTAVE study initial findings reveal vaccine responses in patients with impaired immune systems Published 24th August 2021 These findings are particularly concerning for those treated with rituximab with the highest proportion of …

View Post

Vasculitis: impact of Covid

In News by John Geddes

New research has found that people with rare autoimmune rheumatic diseases (including vasculitis) are at an increased risk of contracting COVID-19 and of COVID-19-related death. The findings demonstrate the urgent …

View Post

‘Freedom Day’ message from VUK

In News by John Geddes

Susan Mills and VUK member Jane Edwards have secured high-profile coverage for VUK’s message that ‘Freedom Day’ poses serious challenges for those whose medical condition may preclude vaccination, or make …

View Post

Freedom Day – for some!

In News by John Geddes

With just over a week to go before the so called ‘Freedom Day’ in England, a coalition of 16 health charities, including Vasculitis UK, are calling on the Government to …

View Post

Survey – Wales Only

In News by John Geddes

RAIRDA have launched a new survey that aims to gather the views and experiences of people living in Wales with rare autoimmune rheumatic diseases (RAIRDs). This will support their submission …

View Post

Call for Employer Support …

In News by John Geddes

… for those who may have get protection from vaccines. A coalition of charities, including Vasculitis U.K. has written an open letter to employers, calling for them to put protective …